CSIMarket
 
Glucotrack Inc   (GCTK)
Other Ticker:  
 
 
Price: $0.2330 $-0.01 -4.233%
Day's High: $0.24 Week Perf: 1.3 %
Day's Low: $ 0.22 30 Day Perf: 5.91 %
Volume (M): 91 52 Wk High: $ 3.75
Volume (M$): $ 21 52 Wk Avg: $0.37
Open: $0.24 52 Wk Low: $0.13



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 10
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0

Glucotrack Inc
Glucotrack Inc is a medical technology company that specializes in the development and manufacturing of non-invasive glucose monitoring devices. The company's flagship product, also called Glucotrack, is designed to help people with diabetes manage their blood sugar levels more easily and conveniently. Unlike traditional glucose monitoring devices that require blood samples, Glucotrack uses a combination of ultrasonic, electromagnetic, and thermal technologies to measure glucose levels in the saliva or outer earlobe. This non-invasive approach eliminates the need for painful finger pricking and provides accurate and real-time glucose readings. The company aims to improve the lives of individuals with diabetes by offering a non-invasive and user-friendly alternative to glucose monitoring.


   Company Address: 301 Rte 17N Rutherford 7070 NJ
   Company Phone Number: (8) 675-7878   Stock Exchange / Ticker: NASDAQ GCTK
   GCTK is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Rewalk Robotics Ltd

Lackluster revenue at LFWD all along the financial fourth quarter of 2023

National Vision Holdings Inc

National Vision Holdings Inc Reports Higher Losses in Latest Financial Results

As a financial journalist, I have been closely analyzing the recent financial results of National Vision Holdings Inc and its impact on the company's performance. In the October to December 2023 interval, National Vision Holdings Inc recorded an expansion in diminishing returns, with a decrease of $0.20 per share compared to $0.12 in the previous year. Additionally, the company saw an improvement in income per share, which increased from $0.94 per share in the previous reporting season.
One area of concern for National Vision Holdings Inc is its business growth, which fell short by 8.28% compared to the corresponding period in the previous year. This is in line with the trend observed in the Medical Equipment and Supplies industry as a whole.

Shockwave Medical Inc

Investors Show Confidence in Shockwave Medical's Financial Performance and Future Growth

Shockwave Medical Inc. has experienced a significant gain in its stock price over the past five trading days, with a 12.01% increase. This rise in stock price has contributed to the company's year-to-date gains of 32.87%. Additionally, Shockwave Medical Inc.'s stock is currently trading on the NASDAQ at 13.1% above its 52-week average. These positive developments indicate that investors have confidence in the company and its future prospects.
In its recent financial report for the three months and full year ended December 31, 2023, Shockwave Medical Inc. highlighted several key achievements. The company's earnings per share (EPS) soared to $1.15, a significant increase compared to the previous year. This improvement can be attributed to the company's growing revenue, which saw a remarkable growth rate of 41.361% to reach $203.60 million.

Teleflex Incorporated

Teleflex Incorporated's Fourth Quarter Earnings: Revenue Up, But Profits Down

Teleflex Incorporated's latest financial report for the three months ending December 31, 2023, showed a mixed bag of results for investors. Despite a revenue improvement of 2.094%, the company experienced a significant income decline of -60.67% compared to the same quarter the previous year. Net profits also fell by -60.42% in this period.
The company's earnings per share (EPS) dropped by -77.34% from the previous quarter, coming in at $0.66 per share. However, revenue grew by 3.692% to $773.87 million. Operating earnings fell by -35.87% to $82.468 million, narrowing the operating margin to 10.66%. Teleflex Incorporated also saw a build-up in inventories and accounts receivable, signaling rising demand for their products.

Artivion Inc

Artivion Inc Hit with $3.38 Million Tax Charge: What This Means for the Company's Future

Financial News Report: Artivion Inc Reports Improved EPS and Revenue Growth in the Fourth Quarter of 2023
Artivion Inc, a leading company in the Medical Equipment and Supplies industry, has released its financial report for the fourth quarter of 2023, covering the period from October to December 31. The company has shown significant improvement in its earnings per share (EPS) and revenue compared to the previous year.
In terms of EPS, Artivion Inc experienced a loss of $0.10 per share, which is an increase from a loss of $0.05 per share in the same period last year. However, it is worth noting that the company has shown improvement from the previous financial reporting period, with EPS improving from a loss of $0.24 per share.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com